Avantor Inc (AVTR)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: LABORATORY ANALYTICAL INSTRUMENTS

RADNOR CORPORATE CENTER, BUILDING ONE RADNOR, PA 19087

Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.

Data as of 2021-04-11 08:10:44 -0400
Market Cap18.241 Billion Shares Outstanding574.885 Million Avg 30-day Volume3.49 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.98432 52-week High/Low31.86 / 12.76 Next Earnings Date2021-04-28 Price to Cash FLow (P/CF) 318.6896
Data provided by IEX Cloud
View SEC Filings from AVTR instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 10 7 42.86% 10 (0.6%) 7 (0.44%) 42.86%
Funds Holding: 374 311 20.26% 120 (7.21%) 110 (6.85%) 9.09%
13F shares: 531.522 Million 489.615 Million 8.56% 177.179 Million 200.007 Million -11.41%
% Ownership 91.9049 84.6589 8.56% 30.6359 34.5831 -11.41%
New Positions: 100 83 20.48% 30 40 -25.0%
Increased Positions 176 141 24.82% 47 41 14.63%
Closed Positions 32 26 23.08% 19 12 58.33%
Reduced Positions 79 67 17.91% 39 25 56.0%
Total Calls 2.156 Million 2.027 Million 6.37% 980.7 Thousand 1.297 Million -24.37%
Total Puts 1.237 Million 936.281 Thousand 32.08% 940.9 Thousand 614.1 Thousand 53.22%
PUT/CALL Ratio 0.57 0.46 23.91% 0.96 0.47 104.26%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AVTR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AVTR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

35.9 Thousand total shares from 4 transactions

Exercise Derivative Conversion (M)

28.3 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

COUTURIER CHRISTOPHE EVP, AMEA

  • Officer
177,459 2021-04-05 4

VANDERHAEGEN FREDERIC EVP, EUROPE

  • Officer
243,669 2021-03-09 5

WONDRASCH MICHAEL EVP & CIO

  • Officer
145,438 2021-03-02 7

BROPHY GERARD EVP, BIOPHARMA PRODUCTION

  • Officer
241,358 2021-02-25 8

SZLOSEK THOMAS A EVP & CFO

  • Officer
325,348 2021-02-25 4

MURRAY MARK CHRISTOPHER EVP, BIOMATERIALS & AT

  • Officer
45,945 2021-02-25 2

HENRICHWARK SVEN EVP, APAC REGION

  • Officer
37,366 2021-02-25 1

OHRI DEVASHISH EVP, IMEA

  • Officer
173,452 2021-02-25 7

PEACOCK JONATHAN M

  • Director
168,431 2021-02-25 1

BRAMWELL JAMES EVP, STRATEGIC PARTNERS

  • Officer
138,205 2021-02-25 5

SACHDEV RAKESH

  • Director
32,841 2021-02-25 1

STUBBLEFIELD MICHAEL PRESIDENT AND CEO

  • Officer
  • Director
1,743,673 2021-02-25 5

ECK STEVEN W SVP & CHIEF ACCOUNTING OFFICER

  • Officer
51,990 2021-02-25 5

SHAW CHRISTI

  • Director
18,555 2021-02-25 2

ANDRES JUAN

  • Director
22,187 2021-02-25 1

MILLER JUSTIN EVP & GENERAL COUNSEL

  • Officer
147,921 2021-02-25 4

GUPTA RAJIV

  • Director
1,447,952 2021-02-25 3

SEVERINO MICHAEL

  • Director
17,258 2021-02-25 3

SUMME GREGORY L

  • Director
14,818 2021-02-25 3

HENSON MEGHAN EVP, CHIEF HR OFFICER

  • Officer
52,249 2021-02-25 3

LEWIS SHERI EVP, GLOBAL OPS & SUPPLY CHAIN

  • Officer
110,767 2021-02-25 3

NEW MOUNTAIN INVESTMENTS III, LLC

NEW MOUNTAIN PARTNERS III LP

NEW MOUNTAIN CAPITAL, L.L.C.

NEW MOUNTAIN CAPITAL GROUP, L.P.

NM HOLDINGS GP, L.L.C.

KLINSKY STEVEN B

  • 10% Owner
28,000,000 2020-11-10 1

GOLDMAN SACHS & CO. LLC

STONEBRIDGE 2017, L.P.

STONEBRIDGE 2017 OFFSHORE, L.P.

VWR PARTNERS, L.P.

BROAD STREET PRINCIPAL INVESTMENTS, L.L.C.

BRIDGE STREET OPPORTUNITY ADVISORS, L.L.C.

GOLDMAN SACHS GROUP INC

STONEBRIDGE 2018 OFFSHORE, L.P.

STONEBRIDGE 2018, L.P.

43,483,708 2020-08-21 2

NATAURI JO

43,483,708 2020-08-21 2

MCALLISTER ERIC EVP, CHRO

  • Officer
197,899 2020-05-17 2

FOXE TANYA EVP, OPERATIONS & SUPPLY CHAIN

  • Officer
39,458 2020-02-21 0

CONNOLLY THOMAS

131,487,059 2019-06-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

COUTURIER CHRISTOPHE - Officer EVP, AMEA

2021-04-07 17:52:50 -0400 2021-04-05 A 8,267 a 177,459 direct 0.6662 0.6662 2 0.0 1

VANDERHAEGEN FREDERIC - Officer EVP, EUROPE

2021-03-10 17:08:56 -0500 2021-03-09 S 10,000 $28.21 d 243,669 direct 0.675 0.0 3.3037 3 -1.0657 5

WONDRASCH MICHAEL - Officer EVP & CIO

2021-03-03 17:11:00 -0500 2021-03-02 S 3,036 $28.71 d 145,438 direct 1.6369 4.7247 4.7247 6 -0.186 3

SEVERINO MICHAEL - Director

2021-03-01 17:34:50 -0500 2021-02-25 A 7,236 a 17,258 direct -4.0014 -2.3312 0.0 1 -6.6458 5

HENSON MEGHAN - Officer EVP, CHIEF HR OFFICER

2021-03-01 17:30:22 -0500 2021-02-25 A 26,347 a 26,347 direct

BRAMWELL JAMES - Officer EVP, STRATEGIC PARTNERS

2021-03-01 17:31:25 -0500 2021-02-25 A 5,427 a 120,641 direct -4.0014 -2.3312 0.0 1 -6.6458 5

OHRI DEVASHISH - Officer EVP, IMEA

2021-03-01 17:30:41 -0500 2021-02-25 A 17,564 a 17,564 direct

WONDRASCH MICHAEL - Officer EVP & CIO

2021-03-01 17:27:54 -0500 2021-02-25 A 8,140 a 148,474 direct -4.0014 -2.3312 0.0 1 -6.6458 5

BROPHY GERARD - Officer EVP, BIOPHARMA PRODUCTION

2021-03-01 17:25:05 -0500 2021-02-25 A 16,281 a 188,665 direct -4.0014 -2.3312 0.0 1 -6.6458 5

VANDERHAEGEN FREDERIC - Officer EVP, EUROPE

2021-03-01 17:26:56 -0500 2021-02-25 A 52,693 a 52,693 direct

SACHDEV RAKESH - Director

2021-03-01 17:31:47 -0500 2021-02-25 A 7,236 a 32,841 direct -4.0014 -2.3312 0.0 1 -6.6458 5

GUPTA RAJIV - Director

2021-03-01 17:35:44 -0500 2021-02-25 A 7,236 a 1,447,952 direct -4.0014 -2.3312 0.0 1 -6.6458 5

LEWIS SHERI - Officer EVP, GLOBAL OPS & SUPPLY CHAIN

2021-03-01 17:35:16 -0500 2021-02-25 A 13,567 a 66,856 direct -4.0014 -2.3312 0.0 1 -6.6458 5

ANDRES JUAN - Director

2021-03-01 17:38:01 -0500 2021-02-25 A 7,236 a 22,187 direct -4.0014 -2.3312 0.0 1 -6.6458 5

HENRICHWARK SVEN - Officer EVP, APAC REGION

2021-03-01 17:34:19 -0500 2021-02-25 A 17,564 a 17,564 direct

MILLER JUSTIN - Officer EVP & GENERAL COUNSEL

2021-03-01 17:28:50 -0500 2021-02-25 A 26,347 a 26,347 direct

HENSON MEGHAN - Officer EVP, CHIEF HR OFFICER

2021-03-01 17:30:22 -0500 2021-02-25 A 8,140 a 25,902 direct -4.0014 -2.3312 0.0 1 -6.6458 5

SZLOSEK THOMAS A - Officer EVP & CFO

2021-03-01 17:29:27 -0500 2021-02-25 A 52,693 a 52,693 direct

OHRI DEVASHISH - Officer EVP, IMEA

2021-03-01 17:30:41 -0500 2021-02-25 A 5,427 a 155,888 direct -4.0014 -2.3312 0.0 1 -6.6458 5

MURRAY MARK CHRISTOPHER - Officer EVP, BIOMATERIALS & AT

2021-03-01 17:25:55 -0500 2021-02-25 A 26,347 a 26,347 direct

ECK STEVEN W - Officer SVP & CHIEF ACCOUNTING OFFICER

2021-03-01 18:01:18 -0500 2021-02-25 A 19,906 a 19,906 direct

VANDERHAEGEN FREDERIC - Officer EVP, EUROPE

2021-03-01 17:26:56 -0500 2021-02-25 A 16,281 a 253,669 direct -4.0014 -2.3312 0.0 1 -6.6458 5

STUBBLEFIELD MICHAEL - Director - Officer PRESIDENT AND CEO

2021-03-01 17:33:12 -0500 2021-02-25 A 234,192 a 234,192 direct

PEACOCK JONATHAN M - Director

2021-03-01 17:38:22 -0500 2021-02-25 A 7,236 a 168,431 direct -4.0014 -2.3312 0.0 1 -6.6458 5

SHAW CHRISTI - Director

2021-03-01 17:36:27 -0500 2021-02-25 A 7,236 a 18,555 direct -4.0014 -2.3312 0.0 1 -6.6458 5

COUTURIER CHRISTOPHE - Officer EVP, SERVICES

2021-03-01 17:32:22 -0500 2021-02-25 A 21,956 a 21,956 direct

HENRICHWARK SVEN - Officer EVP, APAC REGION

2021-03-01 17:34:19 -0500 2021-02-25 A 5,427 a 19,802 direct -4.0014 -2.3312 0.0 1 -6.6458 5

MILLER JUSTIN - Officer EVP & GENERAL COUNSEL

2021-03-01 17:28:50 -0500 2021-02-25 A 8,140 a 121,574 direct -4.0014 -2.3312 0.0 1 -6.6458 5

BRAMWELL JAMES - Officer EVP, STRATEGIC PARTNERS

2021-03-01 17:31:25 -0500 2021-02-25 A 17,564 a 17,564 direct

SZLOSEK THOMAS A - Officer EVP & CFO

2021-03-01 17:29:27 -0500 2021-02-25 A 16,281 a 272,655 direct -4.0014 -2.3312 0.0 1 -6.6458 5

WONDRASCH MICHAEL - Officer EVP & CIO

2021-03-01 17:27:54 -0500 2021-02-25 A 26,347 a 26,347 direct

BROPHY GERARD - Officer EVP, BIOPHARMA PRODUCTION

2021-03-01 17:25:05 -0500 2021-02-25 A 52,693 a 52,693 direct

MURRAY MARK CHRISTOPHER - Officer EVP, BIOMATERIALS & AT

2021-03-01 17:25:55 -0500 2021-02-25 A 8,140 a 19,598 direct -4.0014 -2.3312 0.0 1 -6.6458 5

ECK STEVEN W - Officer SVP & CHIEF ACCOUNTING OFFICER

2021-03-01 18:01:18 -0500 2021-02-25 A 6,151 a 32,084 direct -4.0014 -2.3312 0.0 1 -6.6458 5

STUBBLEFIELD MICHAEL - Director - Officer PRESIDENT AND CEO

2021-03-01 17:33:12 -0500 2021-02-25 A 72,359 a 1,509,481 direct -4.0014 -2.3312 0.0 1 -6.6458 5

LEWIS SHERI - Officer EVP, GLOBAL OPS & SUPPLY CHAIN

2021-03-01 17:35:16 -0500 2021-02-25 A 43,911 a 43,911 direct

SUMME GREGORY L - Director

2021-03-01 17:37:28 -0500 2021-02-25 A 7,236 a 14,818 direct -4.0014 -2.3312 0.0 1 -6.6458 5

COUTURIER CHRISTOPHE - Officer EVP, SERVICES

2021-03-01 17:32:22 -0500 2021-02-25 A 6,784 a 169,192 direct -4.0014 -2.3312 0.0 1 -6.6458 5

ECK STEVEN W - Officer SVP & CHIEF ACCOUNTING OFFICER

2021-02-26 18:44:05 -0500 2021-02-24 M 8,550 a 28,532 direct 0.9484 -5.7604 0.9484 2 -5.7604 6

BROPHY GERARD - Officer EVP, BIOPHARMA PRODUCTION

2021-02-26 18:34:28 -0500 2021-02-24 S 3,059 $27.93 d 172,384 direct yes 0.9484 -5.7604 0.9484 2 -5.7604 6

ECK STEVEN W - Officer SVP & CHIEF ACCOUNTING OFFICER

2021-02-26 18:44:05 -0500 2021-02-24 F 2,577 $27.94 d 25,955 direct 0.9484 -5.7604 0.9484 2 -5.7604 6

OHRI DEVASHISH - Officer EVP, IMEA

2021-02-23 17:39:51 -0500 2021-02-22 F 1,210 $28.69 d 150,461 direct -1.0737 -1.2527 12.8132 12.8132 31 -3.9728 9

BROPHY GERARD - Officer EVP, BIOPHARMA PRODUCTION

2021-02-23 17:51:35 -0500 2021-02-22 S 19,769 $28.62 d 175,443 direct yes -1.0737 -1.2527 12.8132 12.8132 31 -3.9728 9

COUTURIER CHRISTOPHE - Officer EVP, SERVICES

2021-02-23 17:50:20 -0500 2021-02-22 F 1,313 $28.69 d 162,408 direct -1.0737 -1.2527 12.8132 12.8132 31 -3.9728 9

ECK STEVEN W - Officer SVP & CHIEF ACCOUNTING OFFICER

2021-02-23 17:44:54 -0500 2021-02-22 F 449 $28.69 d 19,982 direct -1.0737 -1.2527 12.8132 12.8132 31 -3.9728 9

BRAMWELL JAMES - Officer EVP, STRATEGIC PARTNERS

2021-02-23 17:41:16 -0500 2021-02-22 F 1,216 $28.69 d 115,214 direct -1.0737 -1.2527 12.8132 12.8132 31 -3.9728 9

BROPHY GERARD - Officer EVP, BIOPHARMA PRODUCTION

2021-02-23 17:51:35 -0500 2021-02-22 M 19,769 $17.67 a 195,212 direct -1.0737 -1.2527 12.8132 12.8132 31 -3.9728 9

WONDRASCH MICHAEL - Officer EVP & CIO

2021-02-23 17:47:47 -0500 2021-02-22 F 1,209 $28.69 d 140,334 direct -1.0737 -1.2527 12.8132 12.8132 31 -3.9728 9

STUBBLEFIELD MICHAEL - Director - Officer PRESIDENT AND CEO

2021-02-23 17:42:28 -0500 2021-02-22 F 10,141 $28.69 d 1,437,122 direct -1.0737 -1.2527 12.8132 12.8132 31 -3.9728 9

SZLOSEK THOMAS A - Officer EVP & CFO

2021-02-23 17:38:55 -0500 2021-02-22 F 2,980 $28.69 d 256,374 direct -1.0737 -1.2527 12.8132 12.8132 31 -3.9728 9

BROPHY GERARD - Officer EVP, BIOPHARMA PRODUCTION

2021-02-23 17:51:35 -0500 2021-02-22 M 19,769 d 59,306 direct

BROPHY GERARD - Officer EVP, BIOPHARMA PRODUCTION

2021-02-23 17:51:35 -0500 2021-02-22 F 3,072 $28.69 d 175,443 direct -1.0737 -1.2527 12.8132 12.8132 31 -3.9728 9

MILLER JUSTIN - Officer EVP & GENERAL COUNSEL

2021-02-23 17:46:07 -0500 2021-02-22 F 1,350 $28.69 d 113,434 direct -1.0737 -1.2527 12.8132 12.8132 31 -3.9728 9

VANDERHAEGEN FREDERIC - Officer EVP, EUROPE

2021-02-23 17:43:33 -0500 2021-02-22 F 398 $28.69 d 237,388 direct -1.0737 -1.2527 12.8132 12.8132 31 -3.9728 9

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
AVANTOR INC AVTR 2021-04-12 22:15:03 UTC -0.2014 0.2614 8600000
AVANTOR INC AVTR 2021-04-12 21:45:03 UTC -0.2014 0.2614 8600000
AVANTOR INC AVTR 2021-04-12 21:15:02 UTC -0.2014 0.2614 8600000
AVANTOR INC AVTR 2021-04-12 20:45:03 UTC -0.2014 0.2614 8600000
AVANTOR INC AVTR 2021-04-12 20:15:03 UTC -0.2014 0.2614 8600000
AVANTOR INC AVTR 2021-04-12 19:45:03 UTC -0.2014 0.2614 8600000
AVANTOR INC AVTR 2021-04-12 19:15:03 UTC -0.2014 0.2614 8600000
AVANTOR INC AVTR 2021-04-12 18:45:03 UTC -0.2031 0.2631 8600000
AVANTOR INC AVTR 2021-04-12 18:15:03 UTC -0.2031 0.2631 8600000
AVANTOR INC AVTR 2021-04-12 17:45:03 UTC -0.2031 0.2631 8600000
AVANTOR INC AVTR 2021-04-12 17:15:03 UTC -0.2031 0.2631 8600000
AVANTOR INC AVTR 2021-04-12 16:45:03 UTC -0.1952 0.2552 8600000
AVANTOR INC AVTR 2021-04-12 16:15:03 UTC -0.1952 0.2552 8600000
AVANTOR INC AVTR 2021-04-12 15:45:03 UTC -0.1952 0.2552 8600000
AVANTOR INC AVTR 2021-04-12 15:15:02 UTC -0.1952 0.2552 8600000
AVANTOR INC AVTR 2021-04-12 14:45:03 UTC -0.1911 0.2511 8600000
AVANTOR INC AVTR 2021-04-12 14:15:03 UTC -0.1911 0.2511 8600000
AVANTOR INC AVTR 2021-04-12 13:45:03 UTC -0.1911 0.2511 8600000
AVANTOR INC AVTR 2021-04-12 13:15:03 UTC -0.1911 0.2511 8600000
AVANTOR INC AVTR 2021-04-12 12:45:03 UTC -0.1911 0.2511 8600000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund AVTR -118.0 shares, $-1473.82 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund AVTR -19.0 shares, $-237.31 2020-03-31 N-PORT
AQR Funds- AQR Alternative Risk Premia Fund AVTR -1315.0 shares, $-37017.25 2020-12-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund AVTR -238.0 shares, $-2972.62 2020-03-31 N-PORT
ADVISORS' INNER CIRCLE III- Knights of Columbus Long/Short Equity Fund AVTR -3351.0 shares, $-98820.99 2021-01-31 N-PORT
Calamos Investment Trust/IL- Calamos Market Neutral Income Fund AVTR -1115900.0 shares, $-32907891.0 2021-01-31 N-PORT

Elevate your investments